00-a-day hepatitis C drug approved to treat prison inmates in Illinois
The local newspaper reports Sovaldi will cost state taxpayers $ 61 million if only one third of prisoners with hepatitis C receive the drug, compared with current treatment costs of $ 8 million. John Maki of the John Howard Association, a prison watchdog …
Read more on CBS News